Literature DB >> 1314859

Dehydroepiandrosterone sulphate plasma levels in normal women and patients with benign breast disease.

E Parlati1, I Liberale, P Morelli, P Serva, A Travaglini, A Piccione, E Menini, S Dell'Acqua.   

Abstract

Dehydroepiandrosterone sulphate plasma levels were measured in patients with benign breast disease and in healthy women. In addition the adrenal secretion of dehydroepiandrosterone sulphate was assessed by means of an ACTH stimulation test in some patients and control subjects. The results obtained demonstrate that dehydroepiandrosterone sulphate plasma levels of patients with benign breast disease overlap those found in controls and that the adrenal response to ACTH of patients with breast pathology does not differ from that of healthy women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314859     DOI: 10.1007/BF03348672

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man.

Authors:  E Nieschlag; D L Loriaux; H J Ruder; I R Zucker; M A Kirschner; M B Lipsett
Journal:  J Endocrinol       Date:  1973-04       Impact factor: 4.286

2.  Effects of adrenocortical and gonadal steroids on the secretion in vitro of corticotrophin and its hypothalamic releasing factor.

Authors:  J C Buckingham
Journal:  J Endocrinol       Date:  1982-04       Impact factor: 4.286

3.  Serum progesterone concentration during the luteal phase in women with benign breast disease.

Authors:  P V Walsh; R D Bulbrook; P M Stell; D Y Wang; I W McDicken; W D George
Journal:  Eur J Cancer Clin Oncol       Date:  1984-11

4.  Prolactin secretion and dehydroepiandrosterone sulphate plasma levels in women with benign breast disease.

Authors:  E Parlati; I Liberale; A Travaglini; P Morelli; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

5.  Accumulation of hormones in breast cyst fluid.

Authors:  H L Bradlow; M K Schwartz; M Fleisher; J S Nisselbaum; R Boyar; J O'Connor; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1979-11       Impact factor: 5.958

6.  Serum prolactin levels in patients with fibrocystic breast disease.

Authors:  F Peters; W Schuth; B Scheurich; M Breckwoldt
Journal:  Obstet Gynecol       Date:  1984-09       Impact factor: 7.661

7.  Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease.

Authors:  G Boccuzzi; E Brignardello; M Massobrio; L Bonino
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

8.  [Benign breast diseases: hormonal studies in 125 cases (author's transl)].

Authors:  P Mauvais-Jarvis; F Kuttenn; I Mowszowicz; R Sitruk-Ware
Journal:  Nouv Presse Med       Date:  1977-12-24

9.  Plasma and cyst fluid levels of delta 5 and delta 4 steroid hormones in women with gross cystic breast disease.

Authors:  P Inaudi; A Bernabei; W Gioffré; F Franchi; G Mazzullo; V De Leo; N D'Antona
Journal:  Clin Endocrinol (Oxf)       Date:  1987-12       Impact factor: 3.478

10.  Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.

Authors:  E Parlati; A Travaglini; I Liberale; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.